Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

Completed

Conditions studied: Multiple Sclerosis, MS

In brief

To develop a test to characterize and monitor Multiple Sclerosis (MS) disease status and therapy response from a participant's home by analyzing the gene expression from participant self-collected blood samples using a novel fingerstick collection kit.

Key facts

Study ID

NCT03316404

Run by

DxTerity Diagnostics

People needed

1168

Starts

2017-11-07

Expected to finish

2020-02-25

Last updated by the study team

2024-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients age 18 or older
• Have a permanent address in the United States for the duration of the study
• Have an email address and access to the internet for the duration of the study
• Able to provide informed consent
• Self-reported diagnosis of MS

You may not qualify if…

• None

Where it is running

• DxTerity Diagnostics — Compton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.